Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Cells face constant threats from inside and out. Thus, they’ve evolved sophisticated stress response pathways such as the unfolded protein response (UPR), ...

AI platform integrates academic and defense research to accelerate rapid antidote discovery and federal stockpiling for emerging chemical threats. SACRAMENTO, Calif., March 19, 2026 /PRNewswire/ -- ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

Karan Arora, senior vice president of advanced assays, AI, and pharma services at Leica Biosystems outlines the critical role diagnostics have to play in unlocking the promise of precision medicine.

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...

Roche now operates over 3,500 Nvidia Blackwell GPUs for AI-driven drug discovery, making it the pharma industry's largest ...

Longevity and AI experts discuss the bottlenecks preventing AI-driven insights from becoming actionable clinical interventions.

Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...

This article describes an automated brain organoid creation workflow using the CellXpress.ai system, beginning with iPSCs and ...

Strengthening collaboration to drive innovation across AI, biomedical research, and translational medicine PUNE, ...